Intralesional and topical treatments for Peyronie’s disease: a narrative review of current knowledge
Asian Journal of Andrology · 2025-03 · 27 (2) · 156-165
DOI: 10.4103/aja202460 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Asian Journal of Andrology, online erschienen am 23.08.2024. Verfasst von Antonio Minore und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Campus Bio-Medico, University of Rome, Rome 00128, Italy. Hauptthemen laut MEDLINE: Penile Induration. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Peyronie’s disease (PD) presents a multifaceted challenge in contemporary urological practice, marked by penile deformity, pain, and the potential for erectile dysfunction. We meticulously explored the existing literature of intralesional/topical interventions, aiming to provide clinicians with a nuanced understanding of available options for comprehensive PD management. To conduct this review, we performed a systematic search using the PubMed, Scopus, and ScienceDirect databases, including the keywords of combination of the “Peyronie’s disease/plastic induration of the penis (PIP) and intralesional/topical treatments”. The study selection was based on adherence to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, resulting in the inclusion of 16 articles. We delve into the effectiveness and safety profiles of collagenase Clostridium histolyticum (CCH), interferon, platelet-rich plasma (PRP), hyaluronic acid, botulinum toxin, stem cell, extracorporeal shock wave therapy (ESWT), and traction therapy, assessing their impact on penile curvature, length improvement, and patient-reported symptoms and outcomes. The best options evaluated are intralesional injections of CCH and penile traction devices, alone or in combination. Despite PD remains a challenge for urologists, the objective of this review is to contribute to the evolving landscape of PD management, fostering informed decision-making, and personalized care for individuals grappling with this challenging condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Urology, Campus Bio-Medico, University of Rome, Rome 00128, Italy.
- Department of Urology, San Filippo Neri Hospital, Rome 00135, Italy.
Zitieren
APA
Minore, A., Cacciatore, L., Presicce, F., Iannuzzi, A., Testa, A., Raso, G., Papalia, R., Martini, M., Scarpa, R. M., & Esperto, F. (2025). Intralesional and topical treatments for Peyronie’s disease: a narrative review of current knowledge. Asian Journal of Andrology, 27(2), 156-165. https://doi.org/10.4103/aja202460
Vancouver
Minore A, Cacciatore L, Presicce F, Iannuzzi A, Testa A, Raso G, et al. Intralesional and topical treatments for Peyronie’s disease: a narrative review of current knowledge. Asian Journal of Andrology. 2025;27(2):156-165. doi:10.4103/aja202460
BibTeX
@article{Minore2025,
author = {Minore, Antonio and Cacciatore, Loris and Presicce, Fabrizio and Iannuzzi, Andrea and Testa, Antonio and Raso, Gianluigi and Papalia, Rocco and Martini, Marco and Scarpa, Roberto Mario and Esperto, Francesco},
title = {Intralesional and topical treatments for Peyronie’s disease: a narrative review of current knowledge},
journal = {Asian Journal of Andrology},
year = {2025},
volume = {27},
number = {2},
pages = {156--165},
doi = {10.4103/aja202460}
}
EUVIMED